Bovie Medical Corporation announced a corporate rebranding and company name change to Apyx Medical Corporation effective January 1, 2019. The company also announced plans to move its stock exchange listing to the NASDAQ Global Select Market from the New York Stock Exchange. The company expects that its common stock will commence trading on the NASDAQ Global Select Market on January 2, 2019, under a new ticker symbol – “APYX”. “We are pleased to join the world’s most innovative and growth-oriented companies listed on NASDAQ and are excited to partner with NASDAQ to leverage trading liquidity, enhanced visibility for issuers, leading technology and cost efficiencies,” said Charlie Goodwin, President and Chief Executive Officer. “We also announced a corporate rebranding and Company name change to Apyx Medical Corporation which is the final milestone resulting from the previously announced divestiture and sale of the Core business segment and Bovie brand to Symmetry Surgical, Inc.”
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.